RecruitingPhase 4

Safety and Efficacy of 18 mm Short Vitrectomy Probe for Pediatric Vitreoretinal Surgeries

Taiwan60 participantsStarted 2024-03-05

Plain-language summary

This study aims to study the safety and efficacy of using an 18 mm short vitrectomy probe for pediatric vitreoretinal surgeries and to investigate the surgeon's comfort and reliability of using the shorter probe.

Who can participate

Age range0 Years – 18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients less than 18 years old * Need vitrectomy due to various etiologies, including retinopathy of prematurity, familial exudative vitreoretinopathy, persistent fetal vasculature, congenital cataract, lens dislocation, open-globe injury, vitreous hemorrhage, or other vitreoretinal diseases. Exclusion Criteria: * Patients who cannot cooperate fully with detailed ophthalmic examinations.

What they're measuring

SAFETY of 18 mm vitrectomy probe in pediatric vitreoretinal surgery

Timeframe: Intraoperatively

SAFETY of 18 mm vitrectomy probe in pediatric vitreoretinal surgery

Timeframe: Intraoperatively

Trial details

NCT IDNCT06520410

SponsorChang Gung Memorial Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-02-28

Contact for this trial

Wei-Chi Wu, MD, PhD

886975365848 weichi666@gmail.com

View on ClinicalTrials.gov More Retinopathy of Prematurity Both Eyes trials